Hematologic Inflammation Indices for Differentiating between Brucella, Pyogenic, and Tuberculous Spondylodiscitis

Area of Science:

• Infectious Diseases
• Hematology
• Inflammation Markers

Background:

• Infectious spondylodiscitis presents diagnostic and therapeutic challenges.
• Hematological inflammation indices (HIIs) are blood-derived markers used in disease assessment.
• Effective differentiation of causative pathogens is crucial for timely management.

Purpose of the Study:

• To evaluate the utility of HIIs in distinguishing between different pathogens causing infectious spondylodiscitis.
• To compare HII scores across Brucella, pyogenic, and tuberculous spondylodiscitis.
• To identify potential diagnostic biomarkers for infectious spondylodiscitis etiology.

Main Methods:

• Retrospective comparative study of 116 patients with infectious spondylodiscitis.
• Categorization into Brucella (n=51), pyogenic (n=43), and tuberculous (n=22) groups based on causative pathogens.
• Derivation and statistical comparison of HIIs (e.g., neutrophil/lymphocyte ratio) from complete blood counts.

Main Results:

• Brucella spondylodiscitis group exhibited significantly lower HII scores compared to the pyogenic group (p < 0.05).
• Brucella spondylodiscitis group also showed significantly lower HII scores than the tuberculous group (p < 0.05).
• No significant difference in HII scores was observed between pyogenic and tuberculous spondylodiscitis groups (p > 0.05).

Conclusions:

• HIIs demonstrate potential in differentiating Brucella spondylodiscitis from pyogenic and tuberculous forms.
• These indices may serve as accessible tools for etiological discrimination in infectious spondylodiscitis.
• Further research could validate HIIs for routine clinical application in diagnosing spondylodiscitis pathogens.